A small molecule drug conjugate (SMDC) of DUPA and a duocarmycin built on the solid phase

Andrew Beekman; Marco Cominetti; Oliver Cartwright; Dale L. Boger; Mark Searcey

doi:10.1039/C9MD00279K

A small molecule drug conjugate (SMDC) of DUPA and a duocarmycin built on the solid phase

Andrew Beekman, Marco Cominetti, Oliver Cartwright, Dale L. Boger, Mark Searcey

School of Pharmacy

Research output: Contribution to journal › Article › peer-review

12 Downloads (Pure)

Abstract

In a proof-of-concept study, solid phase synthesis allowed the rapid generation of a small molecule drug conjugate in which the glutamate carboxypeptidase II (GCPII) targeting small molecule DUPA was conjugated to the alkylating subunit of the potent cytotoxin duocarmycin SA. The targeted SMDC contained a cathepsin B cleavable linker, which was shown to be active and selective against cathepsin B over-expressing and GCPII-expressing tumour cell lines.

Original language	English
Pages (from-to)	2170-2174
Number of pages	5
Journal	MedChemComm
Volume	10
Issue number	12
Early online date	27 Nov 2019
DOIs	https://doi.org/10.1039/C9MD00279K
Publication status	Published - Dec 2019

Access to Document

10.1039/C9MD00279K

Accepted_ManuscriptAccepted author manuscript, 457 KB

Cite this

@article{a5b3d4f7ae0c41628a7ddb096772e306,

title = "A small molecule drug conjugate (SMDC) of DUPA and a duocarmycin built on the solid phase",

abstract = "In a proof-of-concept study, solid phase synthesis allowed the rapid generation of a small molecule drug conjugate in which the glutamate carboxypeptidase II (GCPII) targeting small molecule DUPA was conjugated to the alkylating subunit of the potent cytotoxin duocarmycin SA. The targeted SMDC contained a cathepsin B cleavable linker, which was shown to be active and selective against cathepsin B over-expressing and GCPII-expressing tumour cell lines.",

author = "Andrew Beekman and Marco Cominetti and Oliver Cartwright and Boger, {Dale L.} and Mark Searcey",

year = "2019",

month = dec,

doi = "10.1039/C9MD00279K",

language = "English",

volume = "10",

pages = "2170--2174",

journal = "MedChemComm",

issn = "2040-2503",

publisher = "Royal Society of Chemistry",

number = "12",

}

TY - JOUR

T1 - A small molecule drug conjugate (SMDC) of DUPA and a duocarmycin built on the solid phase

AU - Beekman, Andrew

AU - Cominetti, Marco

AU - Cartwright, Oliver

AU - Boger, Dale L.

AU - Searcey, Mark

PY - 2019/12

Y1 - 2019/12

N2 - In a proof-of-concept study, solid phase synthesis allowed the rapid generation of a small molecule drug conjugate in which the glutamate carboxypeptidase II (GCPII) targeting small molecule DUPA was conjugated to the alkylating subunit of the potent cytotoxin duocarmycin SA. The targeted SMDC contained a cathepsin B cleavable linker, which was shown to be active and selective against cathepsin B over-expressing and GCPII-expressing tumour cell lines.

AB - In a proof-of-concept study, solid phase synthesis allowed the rapid generation of a small molecule drug conjugate in which the glutamate carboxypeptidase II (GCPII) targeting small molecule DUPA was conjugated to the alkylating subunit of the potent cytotoxin duocarmycin SA. The targeted SMDC contained a cathepsin B cleavable linker, which was shown to be active and selective against cathepsin B over-expressing and GCPII-expressing tumour cell lines.

U2 - 10.1039/C9MD00279K

DO - 10.1039/C9MD00279K

M3 - Article

VL - 10

SP - 2170

EP - 2174

JO - MedChemComm

JF - MedChemComm

SN - 2040-2503

IS - 12

ER -